Please login to the form below

Not currently logged in
Email:
Password:

Foot and mouth surfaces again

A new foot and mouth outbreak is confirmed in the UK just days after the government declared the county free from the disease

A new foot and mouth outbreak has been confirmed in the UK just days after the government declared the county free from the disease.

In the latest outbreak located in Egham in the county of Surrey, a pre-emptive cull of cattle had already begun even before the case was confirmed by laboratory tests.

A 10km control zone has been set up around the outbreak area to stop the disease spreading. The EU has shelved plans to lift the export ban on livestock products from the area around the original outbreak.

In August 2007, an investigation blamed the original outbreak on a leaking pipe at the Pirbright animal research site, which hosts the Institute of Animal Health (IAH) and Merial labs.

Merial is a private company owned by US-based Merck and French pharmaceutical company Sanofi-Aventis, while the IAH labs are owned and operated by the UK government.

The Merial site was found to be modern and well maintained and had no problem with biosecurity. The IAH laboratory, however, was an ageing facility and due to be replaced.

In a separate Health and Safety Executive report, it was ìhighly likelyî the virus entered a drainage system shared by IAH and Merial.

The investigation revealed that leaks in the pipes combined with heavy rains could have allowed the virus to reach the surface where vehicles carried it outside the facility.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics